Sanofi
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
(0.0% 1d) (-2.5% 1m) (-18.1% 1y) (0.0% 2d) (1.7% 3d) (3.4% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 118,031,444,049
http://www.sanofi.com
Sec Filling | Patents | 100409 employees
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
vaccine cardiovascular diabetes diabetic
add to watch list Paper trade email alert is off
Press-releases
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Published: 2024-04-25 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
asco meeting
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published: 2024-04-24 (Crawled : 14:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: -0.11%
H: 0.0%
C: 0.0%
asco tumors treatment blood for
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 05:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K
|
|
| O: -5.26%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: -4.49%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 0.27%
H: 0.0%
C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
biopharma
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published: 2024-04-24 (Crawled : 12:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
RLYB | News | $1.59 -8.62% -9.43% 280K
|
|
| O: -5.26%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
VXRT | News | $0.7051 -5.41% -5.72% 1.5M
|
Health Technology
|
| O: -4.49%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
PTCT | News S | $25.19 -0.87% -0.87% 560K
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
NKTR | News | $1.39 -2.11% -2.16% 960K
|
Health Technology
|
| O: 1.81%
H: 0.0%
C: 0.0%
MOR | News | $18.07 0.17% 0.17% 130K
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
AMRN | News | $0.8844 0.13% 0.12% 660K
|
Health Technology
|
| O: 0.57%
H: 1.14%
C: 0.0%
GOOGL | News 4 | $159.18 0.58% 0.58% 22M
|
Technology Services
|
| O: 0.27%
H: 0.0%
C: 0.0%
GOOG | News 4 | $161.05 0.71% 0.7% 19M
|
Technology Services
|
| O: 0.38%
H: 0.0%
C: 0.0%
OCX | News | $2.3 -6.31% -6.74% 41K
|
Health Technology
|
| O: -3.25%
H: 0.0%
C: 0.0%
biopharma
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: 1.21%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.11%
H: 0.97%
C: -0.56%
business update for financial results
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Published: 2024-04-24 (Crawled : 13:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
car-t sanofi
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Published: 2024-04-24 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
LTRN | News | $5.44 -5.72% -6.07% 96K
|
Health Technology
|
| O: 2.77%
H: 0.0%
C: 0.0%
pharma drug key leaders development
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published: 2024-04-24 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -4.62%
H: 4.44%
C: 1.21%
business
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: -1.05%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.82%
H: 0.37%
C: 0.17%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published: 2024-04-23 (Crawled : 05:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
study
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 10000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10